Brain Signal Training to Enhance Affect Down-regulation

Clinical trial NCT06626789 · RECRUITING

Trial details

NCT number: NCT06626789
Sponsor: Central Institute of Mental Health, Mannheim
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2025-04-23
Primary completion: 2027-12-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.